FAM87A

Across TCGA pan-cancer cohorts, FAM87A RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated FAM87A data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher FAM87A RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated FAM87A expression acts as an unfavorable survival marker, although some lineages such as LUAD and MESO show a favorable association.

LUAD, STAD, and UCEC are the cancer types where FAM87A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Quartile	All	0.849	0.673	.003	79	view →
STAD	OS	Median	II,III,IV	0.428	0.701	.004	48	view →
UCEC	OS	Quartile	III,IV	0.408	0.689	.007	32	view →
MESO	DFS	Median	II,III,IV	0.653	0.248	.003	24	view →
READ	DFS	Tertile	III,IV	0.567	0.213	.019	19	view →
THYM	DFS	Tertile	All	0.975	0.686	.002	15	view →
ESCA	DFS	Median	All	0.926	0.454	.006	13	view →
ACC	DFS	Tertile	All	0.403	0.844	.019	12	view →
UCS	OS	Tertile	II,III,IV	0.406	0.763	.016	12	view →
CHOL	DFS	Tertile	All	0.802	0.200	.031	12	view →
UVM	OS	Median	All	0.749	0.980	.026	11	view →
COAD	OS	Tertile	IV	0.895	0.374	.012	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

FAM87A–LUAD (DFS)

Open the LUAD breakdown →